United States · FDA National Drug Code directory

REDEFINE Triple Defense

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
14222-2251_11ce87ce-001f-42c8-8420-b2e9463faf69
Product NDC
14222-2251
Form
CREAM
Composition / generic term
AVOBENZONE, OCTISALATE, OCTOCRYLENE
Labeler
Rodan & Fields
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20201018
Source listing expiry
20271231

Source-listed ingredients

  • OCTOCRYLENE — .07 g/mL
  • OCTISALATE — .05 g/mL
  • AVOBENZONE — .03 g/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 JAR in 1 CARTON (14222-2251-1) / 30 mL in 1 JAR · 14222-2251-1
  • 1 JAR in 1 CARTON (14222-2251-2) / 7 mL in 1 JAR · 14222-2251-2
  • 2 mL in 1 PACKET (14222-2251-3) · 14222-2251-3
  • 1 JAR in 1 CARTON (14222-2251-4) / 15 mL in 1 JAR · 14222-2251-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →